Latest Regentis Biomaterials News & Updates

See the latest news and media coverage for Regentis Biomaterials. We track all announcements, press releases, and industry mentions in real time, all in one place.

Regentis Biomaterials

Hydrogel implant developer for tissue repair

regentis.co.il

Headquarters: Herzliya, Israel
Company type: Public company
Number of employees: 10–50
Industry: Medical Equipment, Supplies & Distribution

Last updated Today

Latest news about Regentis Biomaterials

In short: Regentis Biomaterials advanced its GelrinC platform through clinical expansion, leadership changes, and a $6.5 million private placement.

Company announcements

July 2 Regentis Biomaterials

Regentis Biomaterials completes physician training for GelrinC in Milan

Orthopedic surgeons gained hands-on experience with the cartilage repair technology during the session at Humanitas.

June 4 Regentis Biomaterials

Regentis Biomaterials discusses potential of GelrinC platform.

GelrinC could become the first widely adopted off-the-shelf regenerative cartilage repair platform.

June 4 Regentis Biomaterials

Regentis Biomaterials advances GelrinC toward commercialization

It details pivotal FDA study enrollment, CE Mark status, and collaboration with Humanitas, along with manufacturing scale-up.

May 18 Regentis Biomaterials

Regentis Biomaterials develops and patents new manufacturing process

The solvent-free process increases GelrinC production yield by 400%.

Media coverage

June 17 The Desert Sun

Regentis' GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method

HERZLIYA, IL / ACCESS Newswire / January 20, 2026 / Regentis Biomaterials Ltd., ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on...

June 15 The Globe and Mail

Regentis Biomaterials Appoints Chairman Ehud Geller as CEO After Hazum Resignation

Detailed price information for Regentis Biomaterials Ltd (RGNT-A) from The Globe and Mail including charting and trades.

June 15 USA Today

Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement

HERZLIYA, IL / ACCESS Newswire / June 17, 2026 / Regentis Biomaterials Ltd. ("Regentis" or the "Company") (NYSE...

March 17 Morningstar

Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%

Proprietary process is already patented in several countries and is pending in the U.S. HERZLIYA, IL / ACCESS Newswire / March 17, 2026 / Regentis...

Never miss news about Regentis Biomaterials

Track Regentis Biomaterials and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.